Ovarian Cancer Screening (ROMA Test)
Assessing Ovarian Health with Two Key Markers
Curious about the price?
Get pricing and a plan that fits you quickly through AI consultation.
Recommended For
If any of these apply to you, this treatment can help. Not sure? Check quickly via AI chat.
01Women with pelvic masses
02Women with a family history of ovarian cancer
03Women seeking pre/postmenopausal screening
Key Benefits
See what this treatment can do for you. Results may vary by individual condition.
Improved diagnostic accuracy Combining CA125 and HE4 indicators provides higher sensitivity than a single test.
Consideration of menopausal status Calculates a customized risk index by reflecting the patient's menopausal status in the algorithm.
Epithelial ovarian cancer risk assessment Assists in predicting the risk of epithelial ovarian cancer, which is often difficult to detect early.
How It Works
How this treatment works.
Please Read Before Treatment
Important points to know for safe treatment. Please review carefully beforehand.
This test is a risk assessment tool; a biopsy is required for a final cancer diagnosis.
Levels may increase due to benign conditions such as endometriosis or uterine fibroids.
Results must be interpreted by a specialist alongside clinical symptoms and imaging tests.
Frequently Asked Questions
Common questions answered. Have more? Just ask via AI chat.
It supplements accuracy by measuring HE4 alongside CA125 to reduce false-positive rates compared to CA125 alone.
It is conducted as a standard blood test, and special fasting or prior preparation is generally not required.
It only indicates a higher risk; the exact cause must be identified through additional imaging like ultrasound or CT.